Chief Scientific Officer
Thu, Aug 13, 2026
11d ago
30,000 shares @ $20.26
Decreased holdings by -15.60%
Net across this filing: 0.00% (+0 shares)
2nd largest trade (out of 89)
Planned (10b5-1)
“Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025.”Form 4 footnote
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Net holdings across this filing: +0.0% (+0 shares)
29% win rate · -4.5% median edge vs SPY (14 trades, 90-day · small sample)
Price 45% above 200-day moving average
Small Cap stock — insider trades carry more weight
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).